Pluss Unveils Revolutionary Celsure® XL VIP Pallets: A Game-Changing Solution for Pharmaceutical Industry

India Pharma Outlook team | Tuesday, 02 April 2024

 pharmaceutical, global pharmaceutical market, vacuum-insulated panel (VIP) technology, healthcare

Gurugram, April 2: Pluss, a leading provider of temperature-controlled packaging solutions unveiled Celsure® XL VIP pallets, a groundbreaking innovation set to redefine the standards of pharmaceutical shipping and storage. Designed to meet the growing demands of the global pharmaceutical market, these VIP pallets offer unparalleled reliability, affordability, and sustainability.

Crafted with precision using premium materials and incorporating the latest in vacuum-insulated panel (VIP) technology and phase change material (PCM), the pallets ensure temperature integrity during transit and storage. This launch marks a significant milestone in Pluss' journey, reinforcing its dedication to delivering affordable, temperature-secure solutions to customers worldwide.

Commenting on the launch, Samit Jain, Managing Director of Pluss, stated, “The Celsure® XL VIP pallets represent a significant leap forward in our commitment to delivering temperature-secure medicines affordably. It also strengthens India's position as a world-class provider of quality packaging for pharmaceuticals.”

The pallets address a variety of industry challenges. They ensure precise temperature control with PCM technology and VIP insulation, offering sustainability by being reusable, lower costs with a superior payload-to-volume ratio, and providing operational ease by seamlessly transitioning between air and road transport, ensuring uninterrupted supply chain operations. These locally manufactured solutions aligned with the ‘Atmanirbhar Bharat’ and ‘Make in India’ initiatives.

Udit Mangal, Vice President of Life Sciences and Pharma at Pluss emphasized the company's commitment to innovation and excellence. “Our relentless focus on research and development has enabled us to deliver world-class solutions tailored to the needs of the Indian market and help further India’s strength as a pharmacy of the world,” he said.

The new product was recently unveiled in Chennai by Mr. M. M. Murugappan, Chairman - CUMI and Mr. Sridharan Rangarajan, Managing Director - CUMI (Carborundum Universal Ltd), of the Murugappa Group.

© 2024 India Pharma Outlook. All Rights Reserved.